Abstract

Background: Almost 10% of colorectal cancer patients present with or recur with peritoneal metastases. Currently, the only treatment with curative intent is extensive cytoreductive surgery (CRS) followed by hyperthermic intraperitoneal chemotherapy (HIPEC). More than half of patients undergoing CRS and HIPEC develop prolonged postoperative ileus (POI), defined as more than 5 days without gastrointestinal (GI) function. POI represents a major clinical challenge as it causes nausea, vomiting, stomach cramps and general discomfort for the patient. Currently no efficient treatment exists.

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.